You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 7, July 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Gastrointestinal Diseases
 •Surgical Oncology
 •Colon Cancer
 •Hepatobiliary Surgery
 •Alert me on articles by topic

Genetic and Histological Assessment of Surgical Margins in Resected Liver Metastases From Colorectal Carcinoma

Minimum Surgical Margins for Successful Resection

Norihiro Kokudo, MD; Yoshio Miki, MD; Sachiko Sugai, MS; Akio Yanagisawa, MD; Yo Kato, MD; Yoshihiro Sakamoto, MD; Junji Yamamoto, MD; Toshiharu Yamaguchi, MD; Tetsuichiro Muto, MD; Masatoshi Makuuchi, MD

Arch Surg. 2002;137:833-840.

Hypothesis  There have been few reports on the minimum surgical margins (SMs) required for successful liver resection in patients with colorectal metastases. This minimum requirement may be narrower than the previously recommended margin of 10 mm.

Objectives  To identify the minimum margins by assessing the presence of micrometastases around the tumor using genetic and histological techniques, and to investigate whether SMs are associated with patterns of tumor recurrence or patient survival.

Design  Prospective and retrospective studies.

Setting  Tertiary referral cancer center.

Patients and Methods  Fifty-eight patients who underwent 62 liver resections for hepatic metastasis from colorectal cancer between December 1, 1996, and November 30, 2000, were included in the study. Tissue samples taken from the tumor, surrounding liver parenchyma, and Glisson pedicle near the tumor were tested for K-ras and p53 mutations using the mutant allele–specific amplification method. For the retrospective study on patient outcomes, 194 patients who had undergone liver resections between 1980 and 2000 were analyzed according to their SMs.

Results  Of the 62 sets of samples from liver metastases, 39 were positive for K-ras and p53 gene mutations or both. Micrometastases in the liver parenchyma surrounding colorectal metastases were present in 2.0% (4/199) of tested samples and were located within 4 mm of the tumor border. Micrometastases via Glisson pedicle were more common (14.3% [3/21]), but these were also confined to a short distance from the tumor edge (<=5 mm). Of the 5 micrometastases detected by genetic analysis, only 2 were confirmed by histopathological examination. The analysis of patient outcomes demonstrated that the incidence of cut-end recurrence (relapse in the bed of resection) decreased from 20.0% to a range of 5.6% to 7.5% when the SM is 2 mm or more. The incidence of definite cut-end recurrence in patients with SMs less than 2 m, 2 to 4 mm, and 5 mm or wider was 13.3% (6/45), 2.8% (1/36), and 0% (0/102), respectively. The SM was not a significant prognostic factor in patient survival.

Conclusions  Micrometastases around liver tumors are not common, and most are confined to the immediate vicinity of the tumor border. We propose an SM of 2 mm as a clinically acceptable minimum requirement, which carries approximately a 6% risk of margin-related recurrence. Because liver resection provides the only chance of cure, complete removal of the tumor with a minimum margin is justified when technically unavoidable because of the size, location, number of tumors, or successive resections.


From the Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, University of Tokyo (Drs Kokudo and Makuuchi), Department of Surgery, Cancer Institute Hospital (Drs Kokudo, Sakamoto, Yamamoto, Yamaguchi, and Muto), Department of Human Genome Analysis, Cancer Chemotherapy Center (Dr Miki and Ms Sugai), and Department of Pathology, Cancer Institute (Drs Yanagisawa and Kato), Tokyo, Japan.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Margins during Hepatic Surgery for Colorectal Liver Metastases: Complete Resection not Millimeters Defines Outcome
Pawlik and Vauthey
Ann. Surg. Oncol. 2008;15:677-679.
FULL TEXT  

Comparison Between the Minimum Margin Defined on Preoperative Imaging and the Final Surgical Margin After Hepatectomy for Cancer: How to Manage It?
Elias et al.
Ann. Surg. Oncol. 2008;15:777-781.
ABSTRACT | FULL TEXT  

Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Mulier et al.
Ann. Surg. Oncol. 2008;15:144-157.
ABSTRACT | FULL TEXT  

Surgical Resection of Pulmonary Metastases From Colorectal Cancer: Four Favourable Prognostic Factors
Koga et al.
Jpn J Clin Oncol 2006;36:643-648.
ABSTRACT | FULL TEXT  

Local Recurrences After Intraoperative Radiofrequency Ablation of Liver Metastases: A Comparative Study with Anatomic and Wedge Resections
Elias et al.
Ann. Surg. Oncol. 2004;11:500-505.
ABSTRACT | FULL TEXT  

The Significance of Hepatic Pedicle Lymph Nodes Metastases in Surgical Management of Colorectal Liver Metastases and of Other Liver Malignancies
Jaeck
Ann. Surg. Oncol. 2003;10:1007-1011.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.